Successful treatment of prolonged agranulocytosis caused by acute parvovirus B19 infection with intravenous immunoglobulins

K. Herzog-Tzarfati, E. Shiloah*, M. Koren-Michowitz, S. Minha, M. J. Rapoport

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

A 21-year-old previously healthy male presented with prolonged fever of 3 weeks duration and profound agranulocytosis that did not respond to treatment with granulocyte-stimulating factors. A bone marrow biopsy demonstrated an absence of myeloid lineage. Acute parvovirus B19 infection was diagnosed by the presence of both IgM and IgG anti-parvovirus antibodies. Two days treatment with intravenous immunoglobulins (IVIg) resulted in complete recovery. The role of treatment with immunoglobulins in acute and persistent parvovirus infection is discussed.

Original languageEnglish
Pages (from-to)439-440
Number of pages2
JournalEuropean Journal of Internal Medicine
Volume17
Issue number6
DOIs
StatePublished - Oct 2006

Keywords

  • Agranulocytosis
  • Intravenous immunoglobulin
  • Parvovirus B19

Fingerprint

Dive into the research topics of 'Successful treatment of prolonged agranulocytosis caused by acute parvovirus B19 infection with intravenous immunoglobulins'. Together they form a unique fingerprint.

Cite this